This guidance is based on the Ontario Science Table Recommendations and is supported by the Infectious Disease Service and Pharmacy Department at William Osler Health System.
If prescribers wish to prescribe outside of these guidelines as outlined on the forms, this requires consultation with the Infectious Disease (ID) service. It is unlikely to be supported but this is the appeals mechanism. Pharmacists do not have authority to dispense these medications outside of the criteria on the form unless ID has approved the utilization of the agent in that setting.
A simplified table of therapeutic recommendations for Osler was created by the ID service.
|27 Jan 2022||COVID-19 Treatment Algorithm (OSLER ASP) [Osler Intranet only]|
|14 Apr 2022||Summary Recommendations (OSLER ASP)|
|15 Dec 2022||Critically Ill Patients with COVID-19 – Immunomodulatory Agents (ICU or High Flow O2)|
|15 Dec 2022||Moderately Ill Patients with COVID-19 – Immunomodulatory Agents (On oxygen, admitted)|
|27 Jan 2022||Moderately Ill Patients with COVID-19 – Remdesivir (On oxygen, admitted)|
|14 Apr 2022||Mildly Ill Patients with COVID-19 – Remdesivir (Not on Oxygen)|